Pharmacology, Toxicology and Pharmaceutical Science
Rivaroxaban
91%
Anticoagulant Agent
85%
Dabigatran
79%
Direct Oral Anticoagulant
77%
Heparin
62%
Dabigatran Etexilate
57%
Apixaban
52%
Thromboplastin
52%
Antivitamin K
50%
Atrial Fibrillation
49%
Bleeding
46%
Reagent
44%
Prothrombin
41%
Thrombin
41%
Protein Tyrosine Kinase Inhibitor
39%
Blood Clotting Factor 10a Inhibitor
34%
Thromboembolism
33%
Low Molecular Weight Heparin
30%
Paroxysmal Nocturnal Hemoglobinuria
29%
Viper Venom
29%
Daboia russellii
28%
Drug
28%
Clotting Time
27%
Chronic Myeloid Leukemia
24%
Betrixaban
20%
Edoxaban
20%
Clinical Study
20%
Prospective Study
19%
Survival
19%
Ponatinib
19%
Nilotinib
19%
Dasatinib
19%
Diseases
19%
Emergency
17%
Thrombosis
17%
Toxic Injury
15%
Heparin Induced Thrombocytopenia
14%
Pharmacodynamics
14%
Thrombin Inhibitor
13%
Idarucizumab
13%
Ensure
13%
Drug Interaction
13%
Pharmacokinetics
12%
Heart Infarction
12%
Pathophysiology
11%
Eculizumab
11%
Drug Concentration
11%
Randomized Controlled Trial
11%
Activated Protein C Resistance
11%
Fibrinogen
11%
Medicine and Dentistry
Assay
100%
Patient
78%
Laboratory
57%
Thrombosis
50%
COVID-19
49%
Plasma
48%
Blood Stasis
47%
Coagulation
43%
Heparin
42%
Therapeutic Procedure
41%
Diagnosis
40%
Platelet
37%
Heparin-Induced Thrombocytopenia
33%
Procoagulant
33%
Assessment
32%
Apixaban
31%
Inpatient
30%
Cells
29%
Monitoring
28%
In Vitro
26%
Endothelial Cell
26%
Vaccine
26%
Severe Acute Respiratory Syndrome Coronavirus 2
26%
Antibody
24%
Thrombocytopenia
24%
Thromboplastin
22%
Rivaroxaban
22%
Fibrinogen
21%
Betrixaban
21%
Direct Oral Anticoagulant
21%
Hemostat
21%
Membrane Microparticle
19%
Tyrosine-Kinase Inhibitor
19%
Syndrome
19%
Erythrocyte Concentrate
19%
Paroxysmal Nocturnal Hemoglobinuria
19%
Neutrophil
19%
Cell Survival
19%
Cell Function
19%
Acute Leukemia
18%
Blood
18%
Antigen
17%
Fibrinolysis
17%
Anticoagulation
17%
Infection
17%
Low Molecular Weight Heparin
16%
Ex Vivo
16%
Blood Clotting Factor 10a Inhibitor
15%
Antibody Response
15%
Combination Therapy
15%
Biochemistry, Genetics and Molecular Biology
Thrombin
88%
Coagulation
66%
Hemostasis
50%
Sample
47%
Time
43%
Blood Level
39%
Prothrombin Time
35%
Taxonomy
29%
Partial Thromboplastin Time
29%
Heparin
27%
D-Dimer
26%
Anticoagulation
25%
Rivaroxaban
25%
Thrombin Time
21%
Tyrosine Kinase Inhibitor
19%
Platelet
19%
Antibody
19%
Electric Potential
18%
Antithrombin
18%
SARS Coronavirus
15%
Dose
14%
Fibrinolysis
14%
Tissue Factor Pathway Inhibitor
13%
Fibrinogen
13%
Thrombocyte Aggregation
12%
Myeloid
12%
Impedance
11%
Activated Protein C Resistance
11%
Ponatinib
11%
Disseminated Intravascular Coagulation
11%
Coronavirinae
11%
Hirudin
9%
Spherocytosis
9%
Immune Response
9%
Virus Load
9%
Thrombocyte Activation
9%
Acquired Disorder
9%
Quality Control
9%
Thrombocyte Function
9%
Normal Human
9%
Tandem Mass Spectrometry
9%
Thrombotic Microangiopathy
9%
Cell Survival
9%
Association
9%
All Cause Mortality
9%
Laboratory Technique
9%
Neutralizing Antibody
9%
Heparin-Induced Thrombocytopenia
9%
Thromboplastin
9%
Cell Function
9%